Tag: CAR-T
TGA OKs Novartis CAR-T cell therapy manufacturing in Melbourne
With TGA approval in check, Melbourne will house Australia's first and only commercial manufacturing site for the promising cancer treatment.
Swiss pharmaceutical company Novartis announced...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
